Uterine cancer
MONDO:0002715Primary or metastatic malignant neoplasm involving the uterine corpus and/or the cervix.
Also known as: neoplasm of uterus, tumor of uterus, tumour of uterus, uterine tumor, uterine tumour, uterus neoplasm, cancer of the uterus, cancer of uterus
3990 clinical trials for this condition and its sub-types, 96 tagged with Uterine cancer itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Uterine cancer
-
Cervical cancer 576 trials · 700 incl. sub-types
9 sub-types
- Cervical carcinoma 257 trials · 317 incl. sub-types Sub-types →
- High-grade neuroendocrine carcinoma of the cervix uteri 4 trials
- Malignant neoplasm of endocervix 0 trials · 4 incl. sub-types Sub-types →
- Cervix melanoma 1 trial
- Malignant mixed epithelial and mesenchymal tumor of cervix uteri 0 trials · 1 incl. sub-types Sub-types →
- Cervical Wilms tumor 0 trials
- Malignant germ cell tumor of cervix uteri 0 trials
- Sarcoma of cervix uteri 0 trials Sub-types →
- Uterine ligament cancer 0 trials Sub-types →
-
Endometrial cancer 458 trials · 650 incl. sub-types
2 sub-types
- Endometrial carcinoma 209 trials · 316 incl. sub-types Sub-types →
- Endometrioid stromal sarcoma 2 trials Sub-types →
-
Uterine carcinoma 3 trials · 614 incl. sub-types
9 sub-types
- Cervical carcinoma 257 trials · 317 incl. sub-types Sub-types →
- Endometrial carcinoma 209 trials · 316 incl. sub-types Sub-types →
- Endometrial serous adenocarcinoma 36 trials
- Uterus carcinoma in situ 0 trials · 16 incl. sub-types Sub-types →
- Adenoid cystic carcinoma of the corpus uteri 0 trials
- Papillary carcinoma of the corpus uteri 0 trials
- Squamous cell carcinoma of the corpus uteri 0 trials
- Transitional cell carcinoma of the corpus uteri 0 trials
- Undifferentiated carcinoma of the corpus uteri 0 trials
-
Uterine corpus cancer 33 trials · 85 incl. sub-types
12 sub-types
- Endometrial serous adenocarcinoma 36 trials
- Uterine corpus sarcoma 12 trials · 19 incl. sub-types Sub-types →
- Uterine body mixed cancer 0 trials · 14 incl. sub-types Sub-types →
- Adenoid cystic carcinoma of the corpus uteri 0 trials
- High-grade neuroendocrine carcinoma of the corpus uteri 0 trials
- Low-grade neuroendocrine tumor of the corpus uteri 0 trials
- Malignant germ cell tumor of corpus uteri 0 trials Sub-types →
- Papillary carcinoma of the corpus uteri 0 trials
- Squamous cell carcinoma of the corpus uteri 0 trials
- Transitional cell carcinoma of the corpus uteri 0 trials
- Undifferentiated carcinoma of the corpus uteri 0 trials
- Uterine corpus endometrial carcinoma 0 trials
-
Uterine carcinosarcoma 23 trials · 32 incl. sub-types
2 sub-types
- Carcinosarcoma of the corpus uteri 13 trials
- Cervical carcinosarcoma 0 trials
-
Placenta cancer 0 trials · 1 incl. sub-types
1 sub-type
- Placental choriocarcinoma 1 trial
-
Uterine adnexa cancer 0 trials
2 sub-types
- Broad ligament malignant neoplasm 0 trials Sub-types →
- Round ligament malignant neoplasm 0 trials
Most studied deeper sub-types
-
Cancer combo trial halted early after enrolling only 5 patients
Disease control Stopped earlyThis study tested a new drug (INCB099280) combined with a standard cancer drug (axitinib) in adults with advanced solid tumors that had stopped responding to other treatments. The main goals were to check safety and see if the combination could shrink tumors. The trial was termin…
Phase 1/2 • Sponsor: Incyte Corporation • Aim: Disease control
Last updated Jun 27, 2026 13:03 UTC
-
Common diabetes and acne drugs tested against cancer
Disease control Stopped earlyThis phase 2 trial tested whether combining metformin (a diabetes drug) with doxycycline (an antibiotic) could help treat localized breast and uterine cancers. The study enrolled 29 people who were scheduled for surgery. Researchers looked at changes in certain proteins in the tu…
Phase 2 • Sponsor: Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Cancer combo trial ends before it begins: only one patient enrolled
Disease control Stopped earlyThis early-phase trial aimed to test the safety of combining two drugs, adagrasib and olaparib, in people with advanced solid tumors that have a specific genetic change called KRAS G12C. The study planned to include patients with certain breast, ovarian, pancreatic, and lung canc…
Phase 1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
Experimental cancer drug study halted early
Disease control Stopped earlyThis study tested an experimental drug called SQ3370 in 53 people with advanced solid tumors that had spread or could not be removed by surgery. The goal was to check the drug's safety and find the best dose, as well as see if it could shrink tumors. The study was terminated earl…
Phase 1/2 • Sponsor: Shasqi, Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC